Literature DB >> 34055220

Radiosynthesis and Biological Evaluation of [18F]R91150, a Selective 5-HT2A Receptor Antagonist for PET-Imaging.

Michael Willmann1, Julian Hegger1, Bernd Neumaier1,2, Johannes Ermert1.   

Abstract

Serotonergic 5-HT2A receptors in cortical and forebrain regions are an important substrate for the neuromodulatory actions of serotonin in the brain. They have been implicated in the etiology of many neuropsychiatric disorders and serve as a target for antipsychotic, antidepressant, and anxiolytic drugs. Positron emission tomography imaging using suitable radioligands can be applied for in vivo quantification of receptor densities and receptor occupancy for therapy evaluation. Recently, the radiosynthesis of the selective 5-HT2AR antagonist [18F]R91150 was reported. However, the six-step radiosynthesis is cumbersome and time-consuming with low radiochemical yields (RCYs) of <5%. In this work, [18F]R91150 was prepared using late-stage Cu-mediated radiofluorination to simplify its synthesis. The detailed protocol enabled us to obtain RCYs of 14 ± 1%, and the total synthesis time was reduced to 60 min. In addition, autoradiographic studies with [18F]R91150 in rat brain slices revealed the typical uptake pattern of 5-HT2A receptor ligands.
© 2021 The Authors. Published by American Chemical Society.

Entities:  

Year:  2021        PMID: 34055220      PMCID: PMC8155242          DOI: 10.1021/acsmedchemlett.0c00658

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  48 in total

Review 1.  The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis.

Authors:  W K Kroeze; B L Roth
Journal:  Biol Psychiatry       Date:  1998-12-01       Impact factor: 13.382

Review 2.  (18)F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography.

Authors:  Sean Preshlock; Matthew Tredwell; Véronique Gouverneur
Journal:  Chem Rev       Date:  2016-01-11       Impact factor: 60.622

3.  Synthesis and imaging validation of [¹⁸F]MDL100907 enabled by Ni-mediated fluorination.

Authors:  Hong Ren; Hsiao-Ying Wey; Martin Strebl; Ramesh Neelamegam; Tobias Ritter; Jacob M Hooker
Journal:  ACS Chem Neurosci       Date:  2014-06-03       Impact factor: 4.418

Review 4.  Chemistry for Positron Emission Tomography: Recent Advances in 11 C-, 18 F-, 13 N-, and 15 O-Labeling Reactions.

Authors:  Xiaoyun Deng; Jian Rong; Lu Wang; Neil Vasdev; Lei Zhang; Lee Josephson; Steven H Liang
Journal:  Angew Chem Int Ed Engl       Date:  2019-01-14       Impact factor: 15.336

5.  Preclinical evaluation of [123I]R93274 as a SPECT radiotracer for imaging 5-HT2A receptors.

Authors:  A Abi-Dargham; Y Zea-Ponce; D Terriere; M al-Tikriti; R M Baldwin; P Hoffer; D Charney; J E Leysen; M Laruelle; J Mertens; R B Innis
Journal:  Eur J Pharmacol       Date:  1997-03-05       Impact factor: 4.432

6.  A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.

Authors:  J Blin; G Sette; M Fiorelli; O Bletry; J L Elghozi; C Crouzel; J C Baron
Journal:  J Neurochem       Date:  1990-05       Impact factor: 5.372

7.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors.

Authors:  A Pazos; R Cortés; J M Palacios
Journal:  Brain Res       Date:  1985-11-04       Impact factor: 3.252

8.  Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.

Authors:  M Pompeiano; J M Palacios; G Mengod
Journal:  Brain Res Mol Brain Res       Date:  1994-04

9.  Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats.

Authors:  C Lemaire; R Cantineau; M Guillaume; A Plenevaux; L Christiaens
Journal:  J Nucl Med       Date:  1991-12       Impact factor: 10.057

10.  Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge.

Authors:  David Erritzoe; Abhishekh H Ashok; Graham E Searle; Alessandro Colasanti; Samuel Turton; Yvonne Lewis; Mickael Huiban; Sara Moz; Jan Passchier; Azeem Saleem; John Beaver; Anne Lingford-Hughes; David J Nutt; Oliver D Howes; Roger N Gunn; Gitte M Knudsen; Eugenii A Rabiner
Journal:  Neuropsychopharmacology       Date:  2019-11-12       Impact factor: 8.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.